Dynavax is a Bargain Vaccine Stock Pick

Alternative investors have found plenty of strong bargain opportunities during the Coronavirus Pandemic. Dynavax Technologies Corp. (NASDAQ: DVAX) is a pick that is relevant to the times. The company is most known for its Heplisav hepatitis B vaccine. More recently, it has worked with Medigen Vaccine Biologics to develop a COVID-19 vaccine that is now […]